Medivir to present at the H.C. Wainwright 24th Annual Global Investment Conference

Read more

Medivir to present data on additive efficacy of fostrox in combination with anti-PD1 in nonclinical tumor models at the SITC 2022 Annual Meeting

Read more

Medivir to present at the Pareto Securities´ Healthcare conference

Read more

Partner with Medivir

Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale.